Pacific Wealth Management »

Halozyme Therapeutics shares owned by Pacific Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pacific Wealth Management from 13F filings

Historical chart of Pacific Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pacific Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pacific Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $349k 5.4k 64.63

More positions owned by Pacific Wealth Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Nomura Etf Tr Focused Emerging (EMEQ)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Tr Us Treas Bd Etf (GOVT)
Abbvie (ABBV)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Intel Corporation (INTC)
Abbott Laboratories (ABT)
Sprott Asset Management Physical Silver (PSLV)
Apple (AAPL)
Ishares Tr A Rate Cp Bd Etf (QLTA)
Microsoft Corporation (MSFT)
Halozyme Therapeutics (HALO)
ViaSat (VSAT)
Sprott Asset Management Physical Gold Tr (PHYS)

View all positions for Pacific Wealth Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Alliancebernstein

View all funds holding Halozyme Therapeutics